Active Ingredient: LANSOPRAZOLE
Proprietary Name: LANSOPRAZOLE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207167
Product Number: 001
Approval Date: Mar 28, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information